- Home
- OPI vs PRTG Comparison
OPI vs PRTG Comparison
Compare OPI & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPI
- PRTG
- Stock Information
- Founded
- OPI 2009
- PRTG 1973
- Country
- OPI United States
- PRTG British Virgin Islands
- Employees
- OPI N/A
- PRTG N/A
- Industry
- OPI Real Estate Investment Trusts
- PRTG Oil & Gas Production
- Sector
- OPI Real Estate
- PRTG Energy
- Exchange
- OPI Nasdaq
- PRTG Nasdaq
- Market Cap
- OPI 16.9M
- PRTG 17.7M
- IPO Year
- OPI 2009
- PRTG N/A
- Fundamental
- Price
- OPI $0.19
- PRTG $8.04
- Analyst Decision
- OPI
- PRTG
- Analyst Count
- OPI 0
- PRTG 0
- Target Price
- OPI N/A
- PRTG N/A
- AVG Volume (30 Days)
- OPI 1.1M
- PRTG 50.8K
- Earning Date
- OPI 04-30-2025
- PRTG 06-10-2025
- Dividend Yield
- OPI 20.52%
- PRTG N/A
- EPS Growth
- OPI N/A
- PRTG N/A
- EPS
- OPI N/A
- PRTG N/A
- Revenue
- OPI $476,159,000.00
- PRTG N/A
- Revenue This Year
- OPI N/A
- PRTG N/A
- Revenue Next Year
- OPI N/A
- PRTG N/A
- P/E Ratio
- OPI N/A
- PRTG N/A
- Revenue Growth
- OPI N/A
- PRTG N/A
- 52 Week Low
- OPI $0.18
- PRTG $2.10
- 52 Week High
- OPI $3.02
- PRTG $23.01
- Technical
- Relative Strength Index (RSI)
- OPI 28.91
- PRTG 48.91
- Support Level
- OPI $0.25
- PRTG $7.41
- Resistance Level
- OPI $0.30
- PRTG $8.35
- Average True Range (ATR)
- OPI 0.02
- PRTG 0.68
- MACD
- OPI 0.01
- PRTG -0.09
- Stochastic Oscillator
- OPI 10.83
- PRTG 44.60
About OPI Office Properties Income Trust of Beneficial Interest
Office Properties Income Trust is a United States-based real estate investment trust. Its property portfolio is mainly composed of single-tenant office buildings, as well as multitenant properties, which are leased to parties of high credit quality characteristics. Its major tenant is the U.S. government, followed by other smaller government entities and corporations. The company's properties are spread across the United States. The company has only one segment which is direct ownership of real estate properties.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.